| Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda PK Tumwebaze, MD Conrad, M Okitwi, S Orena, O Byaruhanga, T Katairo, ... Nature communications 13 (1), 6353, 2022 | 78 | 2022 |
| Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study PK Tumwebaze, T Katairo, M Okitwi, O Byaruhanga, S Orena, V Asua, ... The Lancet Microbe 2 (9), e441-e449, 2021 | 53 | 2021 |
| High pathogenicity and low genetic evolution of avian paramyxovirus type I (Newcastle disease virus) isolated from live bird markets in Uganda DK Byarugaba, KK Mugimba, JB Omony, M Okitwi, A Wanyana, MO Otim, ... Virology Journal 11, 1-13, 2014 | 47 | 2014 |
| Susceptibilities of Ugandan Plasmodium falciparum isolates to proteasome inhibitors S Garg, O Kreutzfeld, S Chelebieva, PK Tumwebaze, O Byaruhanga, ... Antimicrobial agents and chemotherapy 66 (10), e00817-22, 2022 | 9 | 2022 |
| Decreased susceptibility of Plasmodium falciparum to both dihydroartemisinin and lumefantrine in northern Uganda. Nat Commun 13: 6353 PK Tumwebaze, MD Conrad, M Okitwi, S Orena, O Byaruhanga, T Katairo, ... | 9 | 2022 |
| Drug susceptibility of Plasmodium falciparum in eastern Uganda: a longitudinal phenotypic and genotypic study. Lancet Microbe 2: e441-e449 PK Tumwebaze, T Katairo, M Okitwi, O Byaruhanga, S Orena, V Asua, ... | 9 | 2021 |
| Decreased Susceptibility to Dihydrofolate Reductase Inhibitors Associated With Genetic Polymorphisms in Ugandan Plasmodium falciparum Isolates O Kreutzfeld, PK Tumwebaze, O Byaruhanga, T Katairo, M Okitwi, ... The Journal of Infectious Diseases 225 (4), 696-704, 2022 | 8 | 2022 |
| Gestational age dating using newborn metabolic screening: A validation study in Busia, Uganda SP Oltman, EA Jasper, R Kajubi, T Ochieng, A Kakuru, H Adrama, ... Journal of global health 11, 2021 | 6 | 2021 |
| Associations between varied susceptibilities to PfATP4 inhibitors and genotypes in Ugandan Plasmodium falciparum isolates O Kreutzfeld, SA Rasmussen, AA Ramanathan, PK Tumwebaze, ... Antimicrobial agents and chemotherapy 65 (10), 10.1128/aac. 00771-21, 2021 | 5 | 2021 |
| Susceptibility of ugandan Plasmodium falciparum isolates to the antimalarial drug pipeline O Kreutzfeld, PK Tumwebaze, M Okitwi, S Orena, O Byaruhanga, ... Microbiology Spectrum 11 (3), e05236-22, 2023 | 4 | 2023 |
| Targeted newborn metabolomics: prediction of gestational age from cord blood EA Jasper, SP Oltman, EE Rogers, JM Dagle, JC Murray, M Kamya, ... Journal of Perinatology 42 (2), 181-186, 2022 | 4 | 2022 |
| Impact of Short-Term Storage on Ex Vivo Antimalarial Susceptibilities of Fresh Ugandan Plasmodium falciparum Isolates M Okitwi, S Orena, K Thomas, PK Tumwebaze, O Byaruhanga, ... Antimicrobial Agents and Chemotherapy 66 (4), e01437-21, 2022 | 1 | 2022 |
| Identifying a next-generation antimalarial trioxolane in a landscape of artemisinin partial resistance MT Klope, P Talukder, BR Blank, S Chelebieva, J Chen, SD Fontaine, ... bioRxiv, 2025.01. 02.631109, 2025 | | 2025 |
| Changes in susceptibility of Plasmodium falciparum to antimalarial drugs in Uganda over time: 2019-2024 M Okitwi, S Orena, PK Tumwebaze, T Katairo, Y Taremwa, O Byaruhanga, ... medRxiv, 2024.12. 31.24319821, 2025 | | 2025 |
| The extended recovery ring-stage survival assay is a scalable alternative for artemisinin susceptibility phenotyping of fresh Plasmodium falciparum isolates M Okitwi, DA Shoue, LA Checkley, S Orena, FG Ceja, Y Taremwa, ... Antimicrobial Agents and Chemotherapy 68 (12), e01183-24, 2024 | | 2024 |
| Ex vivo susceptibilities to ganaplacide and diversity in potential resistance mediators in Ugandan Plasmodium falciparum isolates O Kreutzfeld, S Orena, M Okitwi, PK Tumwebaze, O Byaruhanga, ... Antimicrobial Agents and Chemotherapy 68 (9), e00466-24, 2024 | | 2024 |
| Gametocyte production and transmission fitness of African and Asian Plasmodium falciparum isolates with differential susceptibility to artemisinins NI Proellochs, C Andolina, J Ramjith, R Stoter, GJ van Gemert, ... bioRxiv, 2024.12. 23.630038, 2024 | | 2024 |
| Natural killer cell antibody‐dependent cellular cytotoxicity to Plasmodium falciparum is impacted by cellular phenotypes, erythrocyte polymorphisms, parasite … S Tukwasibwe, SN Lewis, Y Taremwa, K van der Ploeg, KD Press, M Ty, ... Clinical & Translational Immunology 13 (11), e70005, 2024 | | 2024 |
| VARIED SUSCEPTIBILITY TO PROTEASOME INHIBITORS AND ASSOCIATIONS WITH GENETIC POLYMORPHISMS IN PLASMODIUM FALCIPARUM ISOLATES FROM UGANDA S Garg, O Kreutzfeld, S Chelebieva, PK Tumwebaze, O Byaruhanga, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 105 (5), 62-62, 2021 | | 2021 |
| DECREASED SUSCEPTIBILITY TO PFDHFR INHIBITORS ASSOCIATED WITH GENETIC POLYMORPHISMS IN UGANDAN PLASMODIUM FALCIPARUM ISOLATES O Kreutzfeld, P Tumwebaze, O Byaruhanga, T Katairo, M Okitwi, S Orena, ... AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE 105 (5), 62-62, 2021 | | 2021 |
